Interactions between TCF7L2 genotype and growth hormone-induced changes in glucose homeostasis in small for gestational age children

Clinical Endocrinology

Volumn 72, Issue 1, 2010, Pages 47-52

  De Kort, Sandra W K ^a   Mook Kanamori, Dennis O ^b   Jaddoe, Vincent W V ^b   Hokken Koelega, Anita C S ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; INSULIN; TRANSCRIPTION FACTOR 7 LIKE 2;

ALLELE; ARTICLE; BEDTIME DOSAGE; BIRTH WEIGHT; BODY COMPOSITION; BODY FAT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CELL FUNCTION; CHILD; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENOTYPE; GESTATIONAL AGE; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SCHOOL CHILD; SMALL FOR DATE INFANT; TREATMENT DURATION;

BIRTH WEIGHT; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC ASSOCIATION STUDIES; GROWTH DISORDERS; HOMEOSTASIS; HUMAN GROWTH HORMONE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INSULIN; INSULIN RESISTANCE; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; TCF TRANSCRIPTION FACTORS;

EID: 72249087546     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03635.x     Document Type: Article

References (28)

1. Weedon, M.N. (2007) The importance of TCF7L2. Diabetic Medicine, 24, 1062 1066.
2. Scott, L.J., Mohlke, K.L., Bonnycastle, L.L. et al. (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science, 316, 1341 1345.
3. Frayling, T.M., Timpson, N.J., Weedon, M.N. et al. (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science, 316, 889 894.
4. Damcott, C.M., Pollin, T.I., Reinhart, L.J. et al. (2006) Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes, 55, 2654 2659.
5. Saxena, R., Gianniny, L., Burtt, N.P. et al. (2006) Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes, 55, 2890 2895.
6. Raitakari, O.T., Ronnemaa, T., Huupponen, R. et al. (2007) Variation of the transcription factor 7-like 2 (TCF7L2) gene predicts impaired fasting glucose in healthy young adults: the Cardiovascular Risk in Young Finns Study. Diabetes Care, 30, 2299 2301.
7. Lyssenko, V., Lupi, R., Marchetti, P. et al. (2007) Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. Journal of Clinical Investigation, 117, 2155 2163.
8. Wegner, L., Hussain, M.S., Pilgaard, K. et al. (2008) Impact of TCF7L2 rs7903146 on insulin secretion and action in young and elderly Danish twins. Journal of Clinical Endocrinology and Metabolism, 93, 4013 4019.
9. Hofman, P.L., Cutfield, W.S., Robinson, E.M. et al. (1997) Insulin resistance in short children with intrauterine growth retardation. Journal of Clinical Endocrinology and Metabolism, 82, 402 406.
10. Sas, T., Mulder, P., Aanstoot, H.J. et al. (2001) Carbohydrate metabolism during long-term growth hormone treatment in children with short stature born small for gestational age. Clin Endocrinol (Oxf), 54, 243 251.
11. Cauchi, S., Meyre, D., Choquet, H. et al. (2007) TCF7L2 rs7903146 variant does not associate with smallness for gestational age in the French population. BMC Med Genet, 8, 37.
12. Munoz, J., Lok, K.H., Gower, B.A. et al. (2006) Polymorphism in the transcription factor 7-like 2 (TCF7L2) gene is associated with reduced insulin secretion in nondiabetic women. Diabetes, 55, 3630 3634.
13. Cutfield, W.S., Jackson, W.E., Jefferies, C. et al. (2003) Reduced insulin sensitivity during growth hormone therapy for short children born small for gestational age. Journal of Pediatrics, 142, 113 116.
14. Willemsen, R.H., de Kort, S.W., van der Kaay, D.C. et al. (2008) Independent effects of prematurity on metabolic and cardiovascular risk factors in short small-for-gestational-age children. Journal of Clinical Endocrinology and Metabolism, 93, 452 458.
15. Usher, R. McLean, F. (1969) Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation. Journal of Pediatrics, 74, 901 910.
16. Fredriks, A.M., Buuren, S.v., Burgmeijer, R.J.F. et al. (2002) Groeidiagrammen (2e, herziene en vermeerderde druk) Growth diagrams second edition Bohn Stafleu van Loghum, Houten.
17. van Dijk, M., Mulder, P., Houdijk, M. et al. (2006) High serum levels of growth hormone (GH) and insulin-like growth factor-I (IGF-I) during high-dose GH treatment in short children born small for gestational age. Journal of Clinical Endocrinology and Metabolism, 91, 1390 1396.
18. Levy, J.C., Matthews, D.R. Hermans, M.P. (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care, 21, 2191 2192.
19. Cutfield, W.S., Bergman, R.N., Menon, R.K. et al. (1990) The modified minimal model: application to measurement of insulin sensitivity in children. Journal of Clinical Endocrinology and Metabolism, 70, 1644 1650.
20. van Dijk, M., Bannink, E.M., van Pareren, Y.K. et al. (2007) Risk factors for diabetes mellitus type 2 and metabolic syndrome are comparable for previously growth hormone-treated young adults born small for gestational age (sga) and untreated short SGA controls. Journal of Clinical Endocrinology and Metabolism, 92, 160 165.
21. Boston, R.C., Stefanovski, D., Moate, P.J. et al. (2003) MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technol Ther, 5, 1003 1015.
22. Arends, N.J., Boonstra, V.H., Duivenvoorden, H.J. et al. (2005) Reduced insulin sensitivity and the presence of cardiovascular risk factors in short prepubertal children born small for gestational age (SGA). Clin Endocrinol (Oxf), 62, 44 50.
23. Verveke, G. Molenberghs, G. (2001) Linear Mixed Models for Longitudinal Data. Springer-Verlag, Berlin.
24. Littell, R.C., Henry, P.R. Ammerman, C.B. (1998) Statistical analysis of repeated measures data using SAS procedures. Journal of Animal Science, 76, 1216 1231.
25. Reinehr, T., Friedel, S., Mueller, T.D. et al. (2008) Evidence for an influence of TCF7L2 polymorphism rs7903146 on insulin resistance and sensitivity indices in overweight children and adolescents during a lifestyle intervention. Int J Obes (Lond), 32, 1521 1524.
26. Florez, J.C., Jablonski, K.A., Bayley, N. et al. (2006) TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. New England Journal of Medicine, 355, 241 250.
27. Cauchi, S., Meyre, D., Dina, C. et al. (2006) Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes. Diabetes, 55, 2903 2908.
28. Freathy, R.M., Weedon, M.N., Bennett, A. et al. (2007) Type 2 diabetes TCF7L2 risk genotypes alter birth weight: a study of 24,053 individuals. American Journal of Human Genetics, 80, 1150 1161.